4.4 Article

Computer-assisted staging of chronic rhinosinusitis correlates with symptoms

Journal

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY
Volume 5, Issue 7, Pages 637-642

Publisher

WILEY
DOI: 10.1002/alr.21499

Keywords

sinusitis; chronic sinusitis symptoms; computed tomography; computer-assisted image analysis; quality of life; Lund-Mackay; sinonasal

Funding

  1. Pritzker School of Medicine
  2. Icahn School of Medicine
  3. National Institute on Aging
  4. National Institute of Allergy and Infectious Disease [AG036762, AI106683]
  5. University of Chicago Institute for Translational Medicine [UL1TR000430]

Ask authors/readers for more resources

BackgroundThe Lund-Mackay (LM) staging system for chronic rhinosinusitis (CRS) does not correlate with clinical parameters, likely due to its coarse scale. We developed a Modified Lund Mackay (MLM) system, which uses a three-dimensional (3D), computerized method to quantify the volume of mucosal inflammation in the sinuses, and sought to determine whether the MLM would correlate with symptoms and disease-specific quality of life. MethodsWe obtained Total Nasal Symptom Score (TNSS) and 22-item Sino-Nasal Outcome Test (SNOT-22) data from 55 adult subjects immediately prior to sinus imaging. The volume of each sinus occupied by mucosal inflammation was measured using MATLAB algorithms created using customized, image analysis software after manual outlining of each sinus. Linear regression was used to model the relationship between the MLM and the SNOT-22 and TNSS. Correlation between the LM and MLM was tested using Spearman's rank correlation coefficient. ResultsAdjusting for age, gender, and smoking, a higher symptom burden was associated with increased sinonasal inflammation as captured by the MLM ( = 0.453, p < 0.013). As expected due to the differences in scales, the LM and MLM scores were significantly different (p < 0.011). No association between MLM and SNOT-22 scores was found. ConclusionThe MLM is one of the first imaging-based scoring systems that correlates with sinonasal symptoms. Further development of this custom software, including full automation and validation in larger samples, may yield a biomarker with great utility for both treatment of patients and outcomes assessment in clinical trials. (C) 2015 ARS-AAOA, LLC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available